GHK-Cu research

The GHK-Cu evidence base cited here is 3 sources — 2 review. Regulatory status: Not FDA-approved (cosmetic).

• GHK-Cu is a naturally occurring copper tripeptide (glycine-histidine-lysine bound to a copper ion) found in human plasma, saliva, and urine — first identified by Loren Pickart in 1973. Plasma levels fall with age.
• It's unusual because the copper isn't just structural: it acts as an enzyme cofactor (superoxide dismutase for antioxidant defense, lysyl oxidase for collagen/elastin cross-linking), so the peptide is both a signaling molecule and a copper-delivery system.
• The widely-cited '4,000+ genes' figure comes from a computational Connectivity Map database query, not direct measurement in human tissue — it's hypothesis-generating, not confirmatory.

GHK-Cu (copper peptide) is a small tripeptide — glycine, histidine, and lysine — complexed with a copper ion. It's one of the best-known regenerative/aesthetic peptides, studied for wound healing, skin rejuvenation, collagen synthesis, hair-follicle support, and anti-inflammatory effects, and is popular with anti-aging and biohacking crowds.

Formally glycyl-L-histidyl-L-lysine copper complex, GHK-Cu is an endogenous peptide — your body already makes, uses, and metabolizes it. It was first isolated from human plasma in 1973, and its circulating concentration drops substantially with age (reported at roughly 200 ng/mL around age 20, falling to ~80 ng/mL by age 60), which is part of why it's framed as a 'youth' signal that supplementation might restore.

By the numbers it is tiny: a ~405 Da tripeptide (Gly-His-Lys + Cu²⁺). Systemic pharmacokinetics are very fast — reported peak within minutes, a half-life on the order of ~4 minutes, and near-complete clearance inside ~20 minutes. That extremely short systemic half-life is one practical reason the human evidence centers on topical/local delivery, where the peptide acts at the application site rather than relying on sustained circulation.

Its defining feature is the copper ion. In many peptides a metal is incidental; here the copper is functional, serving as a cofactor that drives enzymatic processes (antioxidant SOD activity, collagen/elastin cross-linking via lysyl oxidase) and gets delivered to tissue where copper is needed for repair and new blood-vessel formation.

• Weeks 1–2: reported improvements in skin hydration/texture and a subtle 'glow'; in animal wound models some wounds closed within ~14 days.
• Weeks 3–4: reported gains in firmness/elasticity and softening of fine lines; measurable collagen/ECM changes in animal models.
• Weeks 6–8: more visible skin-quality improvement, including wrinkle-depth reduction in reports.

• Stimulates collagen I/III, elastin, and glycosaminoglycan synthesis in fibroblasts and skin models.
• Shifts pro-inflammatory cytokines (TNF-α, IL-6, TGF-β) toward anti-inflammatory outcomes.
• Upregulates antioxidant defense via copper-dependent SOD activity.
• Accelerates wound re-epithelialization and granulation-tissue formation in animal wound models.
• Enlarges hair follicles and stimulates follicle growth in rodent models.

The wound-healing and collagen-synthesis data is robust and mechanistically well-understood. The Connectivity Map gene-modulation data is compelling but computational — hypothesis-generating, not confirmatory.

• GHK-Cu + BPC-157 — complementary repair: BPC-157 for gut/tendon, GHK-Cu for systemic collagen/skin support.
• GHK-Cu + TB-500 — healing stack pairing TB-500's cell migration/angiogenesis with GHK-Cu's collagen stimulation.
• GHK-Cu + GH secretagogues (Ipamorelin, CJC-1295) — for recovery synergy.

The main, well-defined safety concern is copper homeostasis (Wilson's disease). Serious adverse effects are otherwise rare in reports.

• Not FDA-approved as a drug for any medical indication.
• Not a DEA-controlled substance; legal to possess in most jurisdictions.

GHK-Cu is not currently on the WADA Prohibited List (as of 2026), unlike BPC-157 and TB-500. That said, peptides face growing anti-doping scrutiny and the list changes yearly — tested athletes should verify the current list with their governing body before use rather than assume permanent permitted status.

On the Huberman Lab podcast, Dr. Abud Bakri sorted GHK-Cu's evidence into tiers. Topical GHK-Cu has the best human data (photo-aged skin; its discoverer Loren Pickart compared it favorably to retinol and vitamin C) and shows interesting synergy with red/near-infrared light. A practical authenticity check he offered: a genuine copper-peptide product should be visibly blue — many 'research-chem' topicals are not.

All citations link to the original source (PubMed, journal site, or regulatory filing). Independent research database — no vendor influence on what's cited.